GR3031684T3 - 15-Deoxyspergualine-related compounds, process for their preparation and their application in therapy - Google Patents

15-Deoxyspergualine-related compounds, process for their preparation and their application in therapy

Info

Publication number
GR3031684T3
GR3031684T3 GR990402774T GR990402774T GR3031684T3 GR 3031684 T3 GR3031684 T3 GR 3031684T3 GR 990402774 T GR990402774 T GR 990402774T GR 990402774 T GR990402774 T GR 990402774T GR 3031684 T3 GR3031684 T3 GR 3031684T3
Authority
GR
Greece
Prior art keywords
deoxyspergualine
therapy
preparation
application
related compounds
Prior art date
Application number
GR990402774T
Other languages
English (en)
Inventor
Luc Lebreton
Patrice Renaut
Christine Dumas
Original Assignee
Fournier Ind & Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fournier Ind & Sante filed Critical Fournier Ind & Sante
Publication of GR3031684T3 publication Critical patent/GR3031684T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/14Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic the nitrogen atom of the amino group being further bound to hydrocarbon groups substituted by amino groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24Y being a hetero atom
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Indole Compounds (AREA)
GR990402774T 1995-05-17 1999-10-29 15-Deoxyspergualine-related compounds, process for their preparation and their application in therapy GR3031684T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9505862A FR2734263B1 (fr) 1995-05-17 1995-05-17 Analogues de la 15-deoxyspergualine, leur procede de preparation et leur utilisation en therapeutique

Publications (1)

Publication Number Publication Date
GR3031684T3 true GR3031684T3 (en) 2000-02-29

Family

ID=9479086

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990402774T GR3031684T3 (en) 1995-05-17 1999-10-29 15-Deoxyspergualine-related compounds, process for their preparation and their application in therapy

Country Status (22)

Country Link
US (1) US5733928A (el)
EP (1) EP0743300B1 (el)
JP (1) JP2860778B2 (el)
KR (1) KR960041153A (el)
CN (1) CN1063744C (el)
AT (1) ATE182882T1 (el)
AU (1) AU694342B2 (el)
CA (1) CA2176670C (el)
CZ (1) CZ292373B6 (el)
DE (1) DE69603541T2 (el)
DK (1) DK0743300T3 (el)
ES (1) ES2137634T3 (el)
FR (1) FR2734263B1 (el)
GR (1) GR3031684T3 (el)
HU (1) HUP9601323A3 (el)
NO (1) NO306397B1 (el)
NZ (1) NZ286582A (el)
RU (1) RU2130015C1 (el)
SK (1) SK283372B6 (el)
TW (1) TW354782B (el)
UA (1) UA42798C2 (el)
ZA (1) ZA963775B (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843995A (en) * 1997-07-07 1998-12-01 University Of Medicine And Dentistry Of New Jersey Inhibition of HIV-1 replication using oligocarbamate derivatives
DE19737463A1 (de) * 1997-08-28 1999-03-04 Hoechst Marion Roussel De Gmbh Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden
DE19923961A1 (de) * 1999-05-25 2000-11-30 Euro Nippon Kayaku Gmbh Verwendung von 15-Deoxyspergualin zur Behandlung von hyperreaktiven entzündlichen Erkrankungen und Autoimmunerkrankungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5942356A (ja) * 1982-09-02 1984-03-08 Microbial Chem Res Found スパガリン関連化合物およびその製造法
JPS61129119A (ja) * 1984-11-13 1986-06-17 Microbial Chem Res Found 新規免疫抑制剤
US4990536A (en) * 1989-04-03 1991-02-05 Nippon Kayaku Kabushiki Kaisha Immunopotentiator and spergualin-related compound therefor
FR2698628B1 (fr) * 1992-12-02 1995-02-17 Fournier Ind & Sante Analogues de 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.
FR2716452B1 (fr) * 1994-02-24 1996-05-10 Fournier Ind & Sante Analogues de la 15-déoxyspergualine, leur procédé de préparation et leur utilisation en thérapeutique.

Also Published As

Publication number Publication date
DE69603541D1 (de) 1999-09-09
DE69603541T2 (de) 2000-04-06
HU9601323D0 (en) 1996-07-29
SK63696A3 (en) 1996-12-04
FR2734263B1 (fr) 1997-06-20
DK0743300T3 (da) 2000-01-24
ATE182882T1 (de) 1999-08-15
ZA963775B (en) 1996-11-25
EP0743300B1 (fr) 1999-08-04
UA42798C2 (uk) 2001-11-15
HUP9601323A3 (en) 1998-04-28
JPH0977733A (ja) 1997-03-25
AU5208196A (en) 1996-11-28
NO961891L (no) 1996-11-18
NO306397B1 (no) 1999-11-01
AU694342B2 (en) 1998-07-16
CZ142396A3 (en) 1997-02-12
CA2176670A1 (en) 1996-11-18
SK283372B6 (sk) 2003-06-03
TW354782B (en) 1999-03-21
ES2137634T3 (es) 1999-12-16
NO961891D0 (no) 1996-05-10
JP2860778B2 (ja) 1999-02-24
CZ292373B6 (cs) 2003-09-17
KR960041153A (ko) 1996-12-19
US5733928A (en) 1998-03-31
CN1063744C (zh) 2001-03-28
HUP9601323A2 (en) 1997-05-28
CA2176670C (en) 2002-03-26
EP0743300A1 (fr) 1996-11-20
NZ286582A (en) 1998-07-28
FR2734263A1 (fr) 1996-11-22
CN1143075A (zh) 1997-02-19
RU2130015C1 (ru) 1999-05-10

Similar Documents

Publication Publication Date Title
IL96882A0 (en) Uracil derivatives and pesticides containing the same as active ingredient
CA2160128A1 (en) Urea and amide derivatives and their use in the control of cell membrane potassium channels
HK1011349A1 (en) Urea and amide derivatives having acat inhibitory activity, their preparation and their therapeutic and prophylactic use
HUT59109A (en) Process for producing hydroxymethyl-(methylenecyclopentyl)-purines and -pyrimidines, their pharmaceutically acceptable salts and pharmaceutical compositions comprising same
CA2118812A1 (en) 5-ht4 receptor antagonists
EP0680988A3 (en) Carbamic acid ester derivatives and coating compositions containing them.
DE69837346D1 (de) Anilidderivate, deren herstellung und verwendung
GB8525913D0 (en) Compounds
AU6601294A (en) Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
SG47986A1 (en) A pharmaceutical solution
IL106387A (en) Indole derivatives, their preparation and pharmaceutical compositions containing them
FI955430A0 (fi) Bisyklisiä amidijohdannaisia ja niiden käyttö lihasten jännitystä laukaisevina aineena
GR3031684T3 (en) 15-Deoxyspergualine-related compounds, process for their preparation and their application in therapy
HU9201575D0 (en) Pyrimidone derivatives and their analogues
AU7383387A (en) Amino acid derivatives
EP0481756A3 (en) Benzamide derivatives
AU643759B2 (en) Urea derivatives and salts thereof, pharmaceutical compositions containing the same, and methods for producing the same
IE893956L (en) Novel compounds
NO934741L (no) Fremgangsmåte for minimalisering og kontroll av ischemiske og reperfusjonsskade
DK0427518T3 (da) NMDA-blokerende forbindelser, farmaceutiske præparater, deres fremstilling og anvendelse
ES2085078T3 (es) Uso de imino-derivados de etianaldehido para la fabricacion de un medicamento para el tratamiento de la hipertension.
TW275629B (el)
GR3004095T3 (el)
CA1261341A (en) SPIRO[BENZOFURANE-2(3H),1'-CYCLOHEPTANES]; METHOD AND INTERMEDIATE PRODUCTS FOR PREPARING THEM; THEIR USE AS MEDICINES
AU6176686A (en) Amides of N-acylated amino acids as anticonvulsants